Jooeun Bae is a prominent inventor based in West Roxbury, MA, who has made significant contributions to the field of cancer treatment. With a total of five patents to his name, he has focused on developing innovative therapies that target specific antigens involved in cancer progression.

Latest Patents

Among his latest patents, Jooeun Bae has developed T cell receptors specific to B-cell maturation antigen (BCMA) for the treatment of cancer. This disclosure relates to T cell receptors comprising alpha chains and beta chains that are specific to BCMA, along with T cells comprising these receptors and methods of use thereof. Additionally, he has worked on immunogenic peptides that are specific to BCMA and Transmembrane activator and CAML interactor (TACI) antigens, providing new methods of use for these peptides in cancer therapy.

Career Highlights

Jooeun Bae is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and innovations in cancer treatment. His work has been instrumental in developing therapies that enhance the immune response against cancer cells.

Collaborations

Throughout his career, Jooeun Bae has collaborated with notable colleagues, including Nikhil C. Munshi and Kenneth Carl Anderson. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.

Conclusion

Jooeun Bae's innovative work in developing targeted therapies for cancer showcases his commitment to improving patient outcomes. His contributions to the field are paving the way for new treatment options that harness the power of the immune system.

This text is generated by artificial intelligence and may not be accurate.